← EU Feed

Bioxodes to present final Phase 2a trial results confirming breakthrough potential of BIOX-101 for intracerebral hemorrhage in poster at ESOC 2026

AI Briefing

  • Bioxodes presents Phase 2a trial results of BIOX-101 for intracerebral hemorrhage
  • BIOX-101 shows potential for treating intracerebral hemorrhage
  • Breakthrough results presented at ESOC 2026
Advertisement
Read Original Article